FDA – Medical Alley Association


Relievant Medsystems Announces Publication of ASPN Guidelines on the Diagnosis and Treatment of Vertebrogenic Low Back Pain with Basivertebral Nerve Ablation

Published guidelines with highest evidence rating provide physicians confidence to adopt basivertebral nerve ablation as first-line treatment MINNEAPOLIS – September 20, 2022 – Relievant Medsystems, a company focused on transforming the diagnosis and treatment of vertebrogenic pain, a type of chronic low back pain (CLBP), today announced that the American Society of Pain & Neuroscience (ASPN) multidisciplinary […]

HeartBeam Announces FDA Submission of HeartBeam AIMI™ Product

Submission Seeks Approval for the Company’s Proprietary ECG Technology to Aid in Diagnosis of Heart Attack in $500 million Total Addressable Market 18+ million People in the US have Coronary Artery Disease and Heart Attacks Occur Every 40 Seconds SANTA CLARA, Calif.–(BUSINESS WIRE)– HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary […]

NeuroOne® Submits Special 510(k) to FDA for Evo® sEEG Electrode

Company re-submits application to gain FDA clearance for less than 30 day use EDEN PRAIRIE, Minn., Aug. 9, 2022 /PRNewswire/ — NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that the Company submitted a special 510(k) to […]

Medical Alley Association Commends Senate Committee Passage of User Fee Bill

MEDICAL ALLEY, Minn. – Medical Alley Association welcomes action taken by the Senate Health Education, Labor and Pensions Committee – approving the FDASLA Act of 2022. The bill reauthorizes user fee agreements and includes provisions for which Medical Alley Association has advocated – including clarification to the FDA’s Certificate to Foreign Government (CFG) program and […]

Upsher-Smith Wins Prestigious Diana Award from HDA

Company Named a Best Overall Branded Pharmaceutical Product Manufacturer of the Year MAPLE GROVE, Minn., June 8, 2022 /PRNewswire/ — Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has been honored with a Distribution Industry Award for Notable Achievement in Healthcare (DIANA Award) for “Best Overall Branded Pharmaceutical Product Manufacturer with less than $300M in sales” by the Healthcare Distribution Alliance (HDA). […]

Steris Accepted as First Contract Sterilizer to Participate in the FDA Ethylene Oxide Sterilization Master File Pilot Program

Innovative FDA program reduces regulatory burden Further accelerates shift to Sustainable EO® sterilization services, reducing use of ethylene oxide STERIS is pleased to announce that it has been accepted to participate in the U.S. Food and Drug Administration (FDA) Ethylene Oxide Sterilization Master File Pilot Program (Pilot Program), first announced by the FDA in 2019.  At […]

Sonic Beam Therapy Pioneers HistoSonics Awarded Payment Rate For Novel Histotripsy Procedure in CMS 2022 Final Rule

Medical Alley Association startup member HistoSonics’ novel histotripsy procedure has been awarded procedural payment rate, taking effect on January 1st, 2022 Medical Alley, MN – The Centers for Medicare and Medicaid Services, as part of the 2022 Hospital Outpatient Prospective Payment System (OPPS) final rule, have set a facility procedure payment rate for histotripsy of the […]

Newly Published physIQ and UI Health Study on the Efficacy of Novel COVID-19 Decompensation Index

NIH-funded DeCODe clinical study evaluates FDA-cleared AI analytics platform (pinpointIQTM) and a wearable biosensor to remotely monitor patients with COVID-19 First-in-Kind COVID-19 Decompensation Index (CDI) identifies early signs of worsening health with a lower false alarm rate compared to standard-of-care modalities Findings suggests the potential for wearable sensor-based analytics to detect exacerbation of infectious disease […]

UserWise Facilitates FDA Emergency Use Authorization for Detect™ Over-the-Counter COVID-19 Test

UserWise, Inc., a San Jose, California-based Human Factors consultancy for medical products, conducted an expedited 100-participant FDA-compliant human factors study within a 3-week span to facilitate an Emergency Use Authorization (EUA) for the Detect™ COVID-19 Test for over-the-counter home use. San Jose, CA, November 08, 2021 –(PR.com)– UserWise, Inc., a San Jose, California-based Human Factors consultancy […]

Cardialen Receives FDA Approval to Conduct Clinical Trial of Low-Energy Atrial Fibrillation Treatment

U.S. Food and Drug Administration approval of a clinical trial of Cardialen’s low-energy defibrillation and cardioversion therapy expands the number of leading clinical institutions evaluating its promising MultiPulse™ Therapy. Minneapolis, Nov. 17, 2021 – Cardialen, Inc., has received approval from the U.S. Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin a […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER